Premium
O5‐06‐01: SELECTIVE TARGETING OF AMYLOID‐BETA OLIGOMER SPECIES BY PMN310, A MONOCLONAL ANTIBODY RATIONALLY DESIGNED FOR GREATER THERAPEUTIC POTENCY IN ALZHEIMER'S DISEASE
Author(s) -
Kaplan Johanne,
Gibbs Ebrima,
Silverman Judith M.,
Zhao Beibei,
Wang Jing,
Peng Xubiao,
Plotkin Steven S.,
Cashman Neil R.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4864
Subject(s) - oligomer , monoclonal antibody , potency , antibody , epitope , immunohistochemistry , chemistry , in vitro , amyloid (mycology) , amyloid beta , microbiology and biotechnology , thioflavin , in vivo , pathogenesis , alzheimer's disease , pharmacology , biochemistry , peptide , pathology , biology , immunology , medicine , disease , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom